OVARIAN TISSUE CRYOPRESERVATION IN NONHUMAN PRIMATES
非人类灵长类动物的卵巢组织冷冻保存
基本信息
- 批准号:8357823
- 负责人:
- 金额:$ 5.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAutologousBiocompatible MaterialsBiological PreservationCancer PatientCancer SurvivorClinicalCryopreservationEmbryonic DevelopmentEncapsulatedFemaleFertilityFreezingFundingGoalsGrantHumanLeadershipLifeMacacaMalignant NeoplasmsMethodsMorphologyNational Center for Research ResourcesOocytesOvarianOvarian TissuePatientsPhysiciansPolymersPrimatesPrincipal InvestigatorResearchResearch InfrastructureResourcesRiskSolutionsSourceTechnologyTimeTissuesTransplantationUnited States National Institutes of HealthUniversitiesWomancostimprovednonhuman primatenoveloffspringsteroid hormone
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
This project is part of a Roadmap Consortium (U54 RR02437, T. Woodruff, PI) entitled "The Oncofertility Consortium: Fertility Preservation for Women". The goal is to provide leadership in state-of-the-art cryopreservation technology to practitioners who are preserving human ovarian tissues under the aegis of the National Physicians Cooperative. The specific aim is to optimize ovarian cryopreservation methods in nonhuman primates for restoring fertility in female cancer survivors by comparing novel vitrification freeze-thaw methods to the currently utilized slow freeze method. Although ovarian transplantation after cryopreservation has yielded live human offspring, autologous transfer in many cancer patients carries the risk of re-seeding the patient with her own cancer. In these patients, encapsulated 3-dimensional (3D) culture of isolated secondary follicles post-thaw may be the best option for fertility preservation. Since slow freezing damages secondary follicles, optimization of ovarian tissue vitrification could bridge a technical gap for patients to utilize frozen ovarian tissue outside of transplantation. For the first time, macaque follicles isolated from vitrified tissue can survive, grow, form an antrum and produce steroid hormones, indicating functional preservation of cryopreserved secondary follicles. The addition of non-permeating polymers to the vitrification solution improved tissue morphology and follicle function in 3D culture. Current efforts are aimed at producing a mature oocyte derived from 3D follicle culture that can fertilize, undergo embryonic development and ultimately produce a live offspring. This project is facilitated by interactions with the Biomaterials Core at Northwestern University. Expected advances will be transferred to clinical efforts at Fertility Centers.
这个子项目是许多利用资源的研究子项目之一
由NIH/NCRR资助的中心拨款提供。子项目的主要支持
而子项目的主要调查员可能是由其他来源提供的,
包括其它NIH来源。 列出的子项目总成本可能
代表子项目使用的中心基础设施的估计数量,
而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。
该项目是路线图联盟(U 54 RR 02437,T。Woodruff,PI),题为“The Oncofertility Consortium:Fertility Preservation for Women”。其目标是提供领先的国家最先进的冷冻保存技术的从业者谁是保存人类卵巢组织的主持下,国家医师合作社。 具体目的是通过比较新型玻璃化冷冻-解冻方法与目前使用的缓慢冷冻方法,优化非人灵长类动物的卵巢冷冻保存方法,以恢复女性癌症幸存者的生育能力。 尽管冷冻保存后的卵巢移植已经产生了活的人类后代,但许多癌症患者的自体移植具有将患者自身的癌症重新播种的风险。在这些患者中,解冻后分离的次级卵泡的封装三维(3D)培养可能是保持生育能力的最佳选择。 由于缓慢冷冻会损害次级卵泡,因此优化卵巢组织玻璃化冷冻可以为患者在移植外利用冷冻卵巢组织填补技术空白。玻璃化冷冻组织中分离的猕猴卵泡第一次能够存活、生长、形成腔并产生类固醇激素,表明冷冻保存的次级卵泡功能得以保存。向玻璃化溶液中添加非渗透性聚合物改善了3D培养中的组织形态和卵泡功能。 目前的努力旨在从3D卵泡培养物中产生成熟的卵母细胞,该卵母细胞可以受精,经历胚胎发育并最终产生活的后代。 该项目是通过与西北大学生物材料核心的互动来促进的。 预期的进展将转移到生育中心的临床工作中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mary B Zelinski其他文献
Mary B Zelinski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mary B Zelinski', 18)}}的其他基金
Cryopreservation and Transplantation of Ovarian Cortical Tissue for Fertility Preservation
卵巢皮质组织的冷冻保存和移植以保存生育能力
- 批准号:
9920744 - 财政年份:2016
- 资助金额:
$ 5.82万 - 项目类别:
Cryopreservation and Transplantation of Ovarian Cortical Tissue for Fertility Preservation
卵巢皮质组织的冷冻保存和移植以保存生育能力
- 批准号:
9288194 - 财政年份:2016
- 资助金额:
$ 5.82万 - 项目类别:
PRE-CLINICAL TRIALS FOR FEMALE FERTILITY PRESERVATION
女性生育力保存的临床前试验
- 批准号:
8357745 - 财政年份:2011
- 资助金额:
$ 5.82万 - 项目类别:
IMPACT OF MATERNAL HIGH FAT DIET ON OFFSPRING OVARIAN FUNCTION
母亲高脂肪饮食对后代卵巢功能的影响
- 批准号:
8357852 - 财政年份:2011
- 资助金额:
$ 5.82万 - 项目类别:
ROLE OF STRESS IN PCOS: NEURONAL MECHANISMS
压力在多囊卵巢综合症中的作用:神经机制
- 批准号:
8357853 - 财政年份:2011
- 资助金额:
$ 5.82万 - 项目类别:
AMH AS PREDICTOR OF FOLLICLE FUNCTION DURING ENCAPSULATED 3D CULTURE IN MACAQUES
AMH 作为猕猴封装 3D 培养期间卵泡功能的预测因子
- 批准号:
8357774 - 财政年份:2011
- 资助金额:
$ 5.82万 - 项目类别:
AMH AS PREDICTOR OF FOLLICLE FUNCTION DURING ENCAPSULATED 3D CULTURE IN MACAQUES
AMH 作为猕猴封装 3D 培养期间卵泡功能的预测因子
- 批准号:
8173239 - 财政年份:2010
- 资助金额:
$ 5.82万 - 项目类别:
PRE-CLINICAL TRIALS FOR FEMALE FERTILITY PRESERVATION
女性生育力保存的临床前试验
- 批准号:
8173193 - 财政年份:2010
- 资助金额:
$ 5.82万 - 项目类别:
相似海外基金
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
- 批准号:
MR/Y019458/1 - 财政年份:2024
- 资助金额:
$ 5.82万 - 项目类别:
Research Grant
Fabrication and Evaluation of Poly(glycerol sebacate) based small diameter vascular graft as a potent substitution for autologous vessels
基于聚(甘油癸二酸酯)的小直径血管移植物作为自体血管有效替代品的制造和评估
- 批准号:
2897580 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Studentship
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head
自体骨髓抽吸浓缩液治疗股骨头坏死
- 批准号:
10658324 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain
识别治疗慢性术后眼痛的自体血清泪液的多模式生物标志物
- 批准号:
10794761 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
SBIR Phase II: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts
SBIR II 期:可注射蛋白质基质,增强自体脂肪移植物的稳定性
- 批准号:
2304430 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Cooperative Agreement
MICA: Strategy for heart repair in Duchenne Muscular Dystrophy (DMD) using genetically engineered autologous Mesoangioblasts
MICA:利用基因工程自体中成血管细胞修复杜氏肌营养不良症 (DMD) 的心脏的策略
- 批准号:
MR/X00466X/1 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Fellowship
Application of Autologous Connective Tissue Sheets Created in Patients' Bodies to Pediatric Cardiac Valvuloplasty and Development of Dedicated Molds
患者体内自体结缔组织片在小儿心脏瓣膜成形术中的应用及专用模具的开发
- 批准号:
23K15543 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
SBIR 第二阶段,主题 429:自体和同种异体细胞治疗制造的新范式
- 批准号:
10976161 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Planning a phase I study of minor salivary gland derived autologous MSCs for prevention of long-term radiation induced xerostomia
计划对小唾液腺来源的自体 MSC 进行 I 期研究,以预防长期辐射引起的口干症
- 批准号:
10720234 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
使用基序新表位肽脉冲的自体树突状细胞对携带带电 HLA-B 结合袋的非小细胞肺癌患者的治疗性疫苗接种策略进行评估。
- 批准号:
10721983 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别: